Product information

Current status:

Marketed

Current status date:

2023-10-31

Original market date: ^{See footnote 1}

2023-10-31

Product name:

ANTICOAGULANT SODIUM CITRATE SOLUTION, USP

Description:

SINGLE USE

DIN:

02529637 Electronic product monograph is not available

Company:

FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
Ontario
Canada M9W 0C8

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

0-Unassigned

Number of active ingredient(s):

1

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

20:12.04.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS

Active ingredient group (AIG) number:^{See footnote5}

0100377001